IDEAYA Biosciences, Inc.
IDYA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$274,477 | -$112,961 | -$58,655 | -$49,762 |
| Dep. & Amort. | $3,834 | $4,008 | $2,101 | $1,725 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $34,746 | $18,489 | $11,629 | $8,237 |
| Change in WC | $11,546 | -$13,207 | -$41,555 | -$17,813 |
| Other Non-Cash | -$23,233 | -$11,553 | -$695 | $1,834 |
| Operating Cash Flow | -$247,584 | -$115,224 | -$87,175 | -$55,779 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,857 | -$2,368 | -$3,443 | -$2,644 |
| Net Acquisitions | $0 | $0 | $33,404 | $67,022 |
| Inv. Purchases | -$1,191,309 | -$595,980 | -$255,808 | -$314,996 |
| Inv. Sales/Matur. | $692,607 | $439,892 | $225,847 | $247,974 |
| Other Inv. Act. | $0 | $0 | -$33,404 | -$67,022 |
| Investing Cash Flow | -$502,559 | -$158,456 | -$33,404 | -$69,666 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $654,229 | $309,763 | $94,962 | $143,253 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $13,922 | $10,772 | $2,203 | $2,201 |
| Financing Cash Flow | $677,551 | $362,717 | $97,165 | $145,454 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$72,592 | $89,037 | -$23,414 | $20,009 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $157,775 | $68,738 | $92,152 | $72,143 |
| End Cash | $85,183 | $157,775 | $68,738 | $92,152 |
| Free Cash Flow | -$251,441 | -$117,592 | -$90,618 | -$58,423 |